Korea Bio Association Launches 'Global Mingle' Program to Support Bio Companies' Overseas Expansion

Official logo of the Korea Bio Association's overseas expansion program 'Global Mingle' (Provided by Korea Bio Association)

[Asia Economy Reporter Chunhee Lee] The Korea Bio Association is stepping up to support domestic bio companies in expanding overseas.

On the 15th, the Korea Bio Association announced the launch of the ‘Global Mingle’ program to assist domestic bio companies in their overseas expansion.

Global Mingle is a new international exchange program brand by the Korea Bio Association that supports domestic companies’ overseas expansion through international solidarity and cooperation. It is expected to serve as a bridge for domestic companies facing difficulties in entering foreign markets by hosting events such as open innovation with multinational pharmaceutical companies, overseas expansion consulting through embassies/investment offices in Korea, and investor relations (IR) presentations to overseas investors.

In January, the Korea Bio Association held the first Global Mingle event, ‘Korea BIO X BioCentury X Sidley Austin 2021 Global IR @JPM,’ as a side event of the J.P. Morgan Healthcare Conference. Domestic bio companies conducted IR pitching to overseas investors.

Following this, on the 19th, the second series of Global Mingle will be held: the ‘Embassy/Investment Office Bio Industry Roundtable in Korea.’ With participation from five countries, the theme of this event is ‘Post-COVID-19, Investment Trends and Support Policies in the Bio Sector of Each Country.’ The event will feature presentations from each country followed by a panel discussion on the future outlook of the bio sector. Through this, domestic bio companies aiming to enter these countries will receive the latest information on investment, exports, and regulatory approvals.

Participants include Peter Lescouhier, Ambassador of Belgium to Korea; Julie Quinn, Head of Trade and Investment at the Australian Embassy in Korea; Gregor Kamper, Project Manager for Biotechnology at the German Trade and Investment Agency; Fr?d?ric Girard, Vice President of French Biotech; Adeline-Lee Cobb, Deputy Head of Economic and Trade at the French Embassy in Korea; and representatives from the Spanish Biotechnology Association. The session will be moderated by Ji Donghyun, former President of the National Clinical Trial Support Foundation.

The roundtable will be available for viewing on the Korea Bio Association’s YouTube channel ‘BioTV’ from 2 p.m. on the day. Pre-registration is currently underway.

The Korea Bio Association plans to host additional events in the first half of this year, including the ‘Embassy/Investment Office Bio Industry Roundtable in Korea’ with participation from North and South American and Asian countries, the ‘Open Innovation Challenge’ offering one-on-one meetings with multinational pharmaceutical companies such as Bayer and Boehringer Ingelheim, and the ‘Korea-U.S. Biotech Seminar’ introducing the U.S. bio market, investment, and regulatory systems by sector.

Hwang Juri, Head of Future Growth Division at the Korea Bio Association, stated, “We will do our best to provide practical information and networking support necessary for domestic bio companies aiming to enter the international stage through the Global Mingle program. Through this program, we plan to continuously develop cooperative series to activate global business for our member companies.”

This content was produced with the assistance of AI translation services.